The modified Glasgow prognostic score serves as a robust predictor of unplanned readmission and 1-year mortality in lung cancer patients receiving immune checkpoint inhibitors
Higher mGPS scores significantly correlate with elevated risks of both 30-day unplanned readmission and 1-year mortality among LC patients receiving ICI therapy. Routine mGPS monitoring may warrants further evaluation in prospective multicenter validation studies to inform prophylactic interventions.
Authors
- Sicong Guo (ORCID: https://orcid.org/0009-0004-3196-8804)
- Xue Feng
- C F Wang
- Yin Liu (ORCID: https://orcid.org/0000-0001-6014-061X)
- Qilian Xiong
- Bo Deng
- Ruoqing Lu
Institutions
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Community Health Systems - Lutheran Hospital (US)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/fonc.2025.1698848
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chinese People’s Liberation Army
- Health Commission of Sichuan Province